ArticleBiomedicines2026

Computational Repurposing and Experimental Validation of YBX1 Inhibitors in Hepatocellular Carcinoma.

Omar Karkoutly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.